Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 206

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Caveolae at a glance

Open access
Bastiani, Michele, Parton, Robert G.·2010·Journal of Cell Science

Abstract

The plasma membrane is more than a simple delimitation of the boundary of the cell but is a dynamic multi-domain membrane system participating in numerous cellular processes. In many different cell types, the plasma membrane is heavily decorated with small pits of 60–80 nm in diameter, which constitute a specialized type of microdomain called caveolae. Nowadays, almost 60 years after the first observation of caveolae (Palade, 1953), these enigmatic structures are still a hot topic in cellular biology with questions remaining regarding their formation, regulation, and functions in different cell types and in pathological scenarios.The discovery of the caveolin proteins greatly advanced the study of caveolae, particularly with the subsequent demonstration that caveolin expression induces, and is required for, the formation of caveolae (Drab et al., 2001; Fra et al., 1995; Razani et al., 2001). Caveolins are now known to constitute a family of integral membrane proteins that form the principal membrane components of caveolae. The first reported caveolin protein (also independently described as VIP-21) is now called caveolin-1 (Cav1), after the discovery of the related proteins caveolin-2 (Cav2) and caveolin-3 (Cav3). Cav1, together with Cav2, is expressed in a wide range of tissues with the highest levels of expression in endothelial cells, adipocytes, fibroblasts and smooth-muscle cells. Cav3 appears to be the sole isoform expressed in skeletal and cardiac muscle. The essential role of caveolins for caveola formation was made evident with the generation of Cav1- and Cav3-knockout mice, which completely lack caveolae in the respective tissues and, consequently, exhibit a range of phenotypes including muscle, pulmonary and lipid disorders (Le Lay and Kurzchalia, 2005).The recent characterization of cavin-1 (also known as polymerase I and transcript release factor, PTRF) – a protein initially described as a transcription factor and associated with caveolae in adipocytes – as an essential factor required for the stabilization of caveolae at the plasma membrane (Hill et al., 2008; Liu and Pilch, 2008) brought new insights into caveola biogenesis and suggested that caveola formation can be a dynamically regulated process. Moreover, further investigation of cavin-1 and the other three members of the cavin family in the past two years (Bastiani et al., 2009; Hansen et al., 2009; Hill et al., 2008; McMahon et al., 2009) have revealed additional levels of complexity in the regulation of caveola formation and function.In this review, we summarize the events leading to caveola formation as well as the roles of caveolae in different cell types. The accompanying poster illustrates the biosynthetic pathway for caveola formation, the role of the recently characterized cavin complex in caveola formation, and also proposed functions of caveolae and the association of caveolar proteins with disease conditions.Caveolae at the plasma membrane are characterized by a highly uniform structure, originally described as ‘flask-shaped’ but more recently shown to be ‘cup-shaped’, with an open neck as demonstrated in unfixed fast-frozen material (Richter et al., 2008; Schlormann et al., 2010). Although considered uncoated (in comparison with clathrin coated pits), a coat structure can be observed when specialized techniques are used (Richter et al., 2008; Rothberg et al., 1992). Approximately 144 caveolin molecules have been suggested to be incorporated in a single caveolar structure (Pelkmans and Zerial, 2005).Caveolin is synthesized in the endoplasmic reticulum (ER) in a signal recognition particle (SRP)-dependent manner as an integral membrane protein, and it adopts an unusual hairpin configuration in which the N- and C-termini are exposed to the cytoplasm (Monier et al., 1995) (see poster). Caveolin forms low molecular weight oligomers in the ER and travels to the Golgi complex, in a process dependent on the coat protein complex-II (COPII), where it undergoes another round of oligomerization (Hayer et al., 2009; Pol et al., 2005). Later on in the biosynthetic pathway, caveolin is palmitoylated in the C-terminal region (Dietzen et al., 1995; Parat and Fox, 2001). Exocytic caveolar carriers, containing a defined number of caveolin monomers, were shown to directly travel from the Golgi complex to the plasma membrane (Parton and Simons, 2007; Tagawa et al., 2005). Glycosphingolipids and cholesterol have been suggested to be crucial factors for the budding of these caveolar domains from the Golgi complex, and cholesterol has been shown to be a rate-limiting component for caveolin trafficking from the Golgi complex to the plasma membrane (Pol et al., 2005). The exact mechanisms underlying exit from the Golgi complex and the precise nature of the exocytic carriers are still to be elucidated, but it is apparent that mutations in a number of regions of the caveolin protein disrupt the transport from the Golgi to the cell surface (Kirkham et al

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/jcs.070102

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 206

Metadata

Authors
Bastiani, M., & Parton, R. G.
Venue
Journal of Cell Science
Published
2010-11-15
Volume
123
Issue
22
Pages
3831-3836
ISSN
  • 0021-9533 (ISSN-L)
  • 1477-9137
OpenAlex
W2030194584
Cited by
206
References
3
FWCI
5.82
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.